| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 07/10/2003 | CA2470684A1 A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 07/09/2003 | EP1325757A1 Embolic materials |
| 07/09/2003 | EP1324767A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124190 Methods and compositions for treating pain of the mucous membrane |
| 07/03/2003 | US20030124087 Prevents an adhesion between tissues at an operated legion and have various shapes, comprising sodium carboxymethyl cellulose and gellan gum |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/02/2003 | EP1323436A1 Anti-adhesion barrier comprising carboxymethylcellulose and gellan gum |
| 07/02/2003 | EP1322593A1 O-substituted 6-methyl-tramadol derivatives |
| 07/02/2003 | EP1322592A1 Substituted 1-aminobutan-3-ol derivatives |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 06/26/2003 | US20030118582 Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitors |
| 06/25/2003 | EP1320541A2 Tgf-beta inhibitors and methods |
| 06/19/2003 | WO2003049773A1 Methods for inhibiting ocular processes |
| 06/19/2003 | US20030115620 Major histocompatibility complex; transgenic swine |
| 06/19/2003 | US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits |
| 06/19/2003 | US20030113840 25 human secreted proteins |
| 06/19/2003 | US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 06/18/2003 | EP1319067A2 Human coagulation factor vii variants |
| 06/18/2003 | EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/18/2003 | EP1318833A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/18/2003 | EP1318829A1 Angiogenic agents and their uses |
| 06/18/2003 | EP1318819A1 Treatment of trauma, and other indications |
| 06/18/2003 | CN1424025A Medicine against spinal canal restenosis and use thereof |
| 06/12/2003 | WO2003048166A1 Podophyllotoxins as antiproliferative agents |
| 06/12/2003 | WO2003048160A1 Ring fused pyrazole derivatives |
| 06/12/2003 | WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 06/12/2003 | US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such |
| 06/12/2003 | US20030108620 Prophylactic treatment of secondary injury of tissue traumatic event, surgery, transplant, nonproliferative tissue, burns, using of 3-methylsulfonyl-4-piperidinyl benzoyl)guanidine methanesulfonate or N,N-dimethylamiloride |
| 06/12/2003 | CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
| 06/12/2003 | CA2468927A1 Ring fused pyrazole derivatives |
| 06/11/2003 | EP1317454A2 Caspase inhibitors and uses thereof |
| 06/11/2003 | EP1317283A2 Tweak receptor agonists as anti-angiogenic agents |
| 06/11/2003 | CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand |
| 06/11/2003 | CN1423647A Beta-alanine derivatives and their use as receptor antagonists |
| 06/10/2003 | US6576618 Cholesterol containing cationic liposome having gene encoding insulin like growth factor I |
| 06/05/2003 | WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 06/05/2003 | WO2003045372A1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 06/05/2003 | US20030105104 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 06/05/2003 | US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 06/05/2003 | US20030105061 For use in resecting epithelium |
| 06/05/2003 | CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 06/04/2003 | EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour |
| 06/04/2003 | EP1030676A4 Bonding of cartilaginous matrices using isolated chondrocytes |
| 06/03/2003 | US6572638 Method of controlling body temperature while inhibiting thermoregulatory responses |
| 05/30/2003 | WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 05/30/2003 | WO2002089675A3 Wound closure system and methods |
| 05/30/2003 | WO2002041827A9 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 05/28/2003 | EP1107749B1 Fumaric acid derivatives for the treatment of transplant rejection |
| 05/28/2003 | EP0826373B1 Use of lactoferrin for preventing postoperative astigmatism |
| 05/28/2003 | CN1420882A Substd. oxoazaheterocyclyl compounds |
| 05/28/2003 | CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha |
| 05/27/2003 | US6570002 Inhibitor of programmed cell death |
| 05/22/2003 | WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| 05/22/2003 | WO2003041724A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 05/22/2003 | WO2002022776A9 Human coagulation factor vii variants |
| 05/22/2003 | US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096737 Caspase inhibitors and uses thereof |
| 05/22/2003 | US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/21/2003 | EP1311525A2 Composition and method for inhibiting platelet aggregation |
| 05/21/2003 | EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/21/2003 | CN1419454A Use of lactic acid bacterium for the treatment of peritonitis |
| 05/15/2003 | WO2003040098A1 Novel metalloproteinase inhibitors |
| 05/15/2003 | WO2003039585A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 05/15/2003 | WO2003039580A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 05/15/2003 | WO2002058730A3 Compositions for treatment of ocular neovascularization |
| 05/15/2003 | CA2464614A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 05/14/2003 | EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists |
| 05/14/2003 | EP1309610A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 05/14/2003 | CN1418187A Carboxylic acid derivatives as IP antagonists |
| 05/07/2003 | EP1308164A2 Medical composition comprising a polysaccharide for elevating the epithelium |
| 05/07/2003 | EP1307541A2 Tissue implant for cartilage repair |
| 05/07/2003 | EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 05/07/2003 | CN1415339A Medicament for promoting exhaustion from anus and its preparation method |
| 05/07/2003 | CN1107518C Use of red sage in preventing post-operative adhesion of vertebral canal |
| 05/06/2003 | US6558688 Ocular tissue regeneration inducer |
| 05/01/2003 | WO2003035099A1 Biphasic mixtures of glp-1 and insulin |
| 05/01/2003 | US20030083465 Protein for use in treatment and prevention of angiogenesis |
| 05/01/2003 | US20030083265 TGF-beta inhibitors and methods |
| 05/01/2003 | CA2463803A1 Biphasic mixtures of glp-1 and insulin |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | US20030077245 A polyalkylene oxide-ethylene oxide block copolymer as antigrowth agents |
| 04/24/2003 | US20030077242 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/23/2003 | CN1413100A Local prevention or amelioration of pain from surgically closed wounds |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
| 04/17/2003 | WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |